Drugs / WGA-800CW
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07643727 | Jun 2026 → Mar 2028 expected | Barrett adenocarcinoma, Barrett esophagus | University Medical Center Groningen | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WGA-800CW | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07643727 ↗ |
| Route | Topical | “WGA-800CW will be topically administered via a spray catheter” NCT07643727 ↗ |